Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Aerosol + Low-dose Cisatracurium for Intubation in ERCP
NCT07185074Phase 4Completed
- Start
- Jan 2025
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lidocaine 10% oropharyngeal spray. Started Jan 2025; status: completed.
02
Drugs
lidocaine 10% oropharyngeal spray
Beyond the preview
Go deeper on NCT07185074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07185074.